Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 163,582 | 11,294 | N/A | N/A | N/A |
| Receivables | N/A | 39,669 | N/A | N/A | N/A |
| TOTAL | $169,295 | $56,080 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 2,301 | 529 | 0 | 0 | 0 |
| TOTAL | $2,301 | $529 | $N/A | $N/A | $N/A |
| Total Assets | $171,596 | $56,609 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,851 | 3,329 | 0 | 0 | 0 |
| Accrued Expenses | 2,715 | 4,598 | N/A | N/A | N/A |
| TOTAL | $5,566 | $7,927 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 541 | 211 | 0 | 0 | 0 |
| TOTAL | $541 | $211 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,107 | $8,138 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,010 | N/A | N/A | N/A | N/A |
| Retained earnings | -104,360 | -69,523 | N/A | N/A | N/A |
| Other shareholders' equity | 674 | 117,168 | 0 | 0 | 0 |
| TOTAL | $165,489 | $48,471 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $171,596 | $56,609 | $0 | $0 | $0 |